Resources Contact Us Home
S-dimethylarsino-thiosuccinic acid S-dimethylarsino-2-thiobenzoic acid S-(dimethylarsino) glutathione as treatments for cancer

Image Number 15 for United States Patent #7619000.

Arsenic trioxide, an inorganic compound, is commercially available anti-cancer agent but it carries significant toxicity. Organic arsenicals, on the other hand, are much less toxic, to the extent that the methylation of inorganic arsenic in vivo into organic arsenicals has been considered a detoxification reaction. New organic arsenic derivatives have been synthesized, including S-dimethylarsino-glutathione, S-dimethylarsino-thiosuccinic acid and S-dimethylarsino-thiobenzoic acid, and established its potent in vitro cytotoxic activity against numerous human tumor cell lines, both of solid and hematological origin, as well as against malignant blood cells from patients with leukemia. Results form a basis for the development of S-dimethylarsino-glutathione, S-dimethylarsino-thiosuccinic acid, S-dimethylarsino-thiobenzoic acid, and other organic arsenicals as an anti-cancer therapy, combining high efficacy with very low, if any, toxicity.

  Recently Added Patents
Apparatus and method for recording reboot reason of equipment
Enhanced claims damage estimation using aggregate display
Discharge circuit and method
Data processing apparatus, activation control method, and computer-readable storage medium
5-HT.sub.3 receptor modulators, methods of making, and use thereof
Three-term predictive adder and/or subtracter
  Randomly Featured Patents
Selective removal of olefins from hydrocarbon feed streams
Flower pot cover
Die holder assembly
Magnetic filtering apparatus
Low cost dispenser for multi-component foams
Drive motor mount for clamshell lathe
Vehicle departure detecting device
Device for regenerating a brake particularly for skates
Active safety switch for gas burner